TOPRAZOLE 20/MG EC TAB 15/TAB

Indications

Approved Uses

Erosive esophagitis associated with GERD (healing) and maintenance of healing; pathological hypersecretory conditions including Zollinger-Ellison syndrome.

Off-Label Uses

Off-label (varies by guideline/institution): stress ulcer prophylaxis in critically ill patients (often IV/oral depending on setting), laryngopharyngeal reflux, functional dyspepsia.

Dosage & Administration

Dosing by Condition

Erosive esophagitis (healing): 40 mg orally once daily for up to 8 weeks (some patients may require an additional 8 weeks). Maintenance of healed erosive esophagitis: 20-40 mg once daily. Pathological hypersecretory conditions (e.g., Zollinger-Ellison): start 40 mg twice daily and titrate to clinical response (doses up to 240 mg/day have been used).

Initial Dose

20mg once daily for GERD; 40mg once daily for erosive esophagitis or peptic ulcer

Maintenance Dose

20mg to 40mg once daily for maintenance of healing of erosive esophagitis.

Maximum Dose

240mg per day (Zollinger-Ellison syndrome); 80mg per day for standard indications

Children's Dosage

Approved for children 5 years and older. 15 to <40 kg: 20mg once daily for up to 8 weeks. ≥40 kg: 40mg once daily for up to 8 weeks.

Dose Adjustment Notes

No dose adjustment is required in renal impairment. In hepatic impairment, use caution; some labels recommend not exceeding 20 mg/day in severe hepatic impairment and/or monitoring liver enzymes. No routine dose reduction is recommended solely for CYP2C19 poor metabolizers.

How to Take

Swallow the enteric‑coated tablet whole with water; do not crush, chew, or split. Preferably take before a meal (commonly 30-60 minutes before breakfast for once‑daily dosing).

Safety & Warnings

Contraindications

Hypersensitivity to pantoprazole/other PPIs (substituted benzimidazoles) or excipients; concomitant use with rilpivirine-containing products.

Warnings & Precautions

Key precautions: may mask gastric malignancy-evaluate alarm features; risk of C. difficile diarrhea; hypomagnesemia (consider monitoring if prolonged therapy or with digoxin/diuretics); osteoporosis-related fractures with long-term/high-dose use; vitamin B12 deficiency with long-term use; fundic gland polyps with long-term use; acute interstitial nephritis; consider lupus (cutaneous/systemic) if suggestive symptoms occur.

Age Restriction

Pediatric use depends on indication: for GERD/erosive esophagitis, pantoprazole is generally approved for children ≥5 years; not established/approved for <5 years.

Drug Interactions

Interaction Severity

MAJOR/Contraindicated or avoid: rilpivirine; avoid with atazanavir or nelfinavir (reduced absorption with increased gastric pH). MODERATE: warfarin (monitor INR), high‑dose methotrexate (consider holding PPI/monitor), drugs needing acidic pH for absorption such as ketoconazole/itraconazole (reduced effect), and iron salts (reduced absorption). MINOR: digoxin (possible increased levels, monitor if high risk); clopidogrel interaction is less clinically significant with pantoprazole than with omeprazole/esomeprazole.

Food Interaction

May be taken with or without food, but taking it before a meal (about 30-60 minutes prior) is preferred for best acid suppression.

Special Populations

Pregnancy

Not assigned a pregnancy category (Category C prior to 2015; now uses descriptive text: based on animal data, may cause fetal harm.

Children

Approved for children 5 years and older. 15 to <40 kg: 20mg once daily for up to 8 weeks. ≥40 kg: 40mg once daily for up to 8 weeks.

Storage & Patient Advice

Stopping the Medicine

Can be stopped when clinically appropriate; after prolonged use, consider tapering/step-down to reduce rebound acid hypersecretion.

Patient Counseling

Swallow the enteric‑coated tablet whole (do not crush/chew/split); take once daily preferably 30-60 minutes before a meal for best effect. Use for the prescribed duration; if a dose is missed, take it when remembered unless near the next dose (do not double). Seek medical advice for severe/persistent diarrhea (possible C. difficile), signs of allergy, or symptoms of hypomagnesemia (e.g., muscle cramps/weakness, palpitations/seizures) especially with prolonged use; long‑term therapy may warrant monitoring magnesium and vitamin B12 and may increase fracture risk-ensure adequate calcium/vitamin D if at risk. Check for interactions: may reduce absorption of drugs needing acidic pH (e.g., ketoconazole/itraconazole/erlotinib) and is generally avoided with atazanavir/nelfinavir; use caution/monitoring with warfarin and high‑dose methotrexate.

Monitoring Requirements

For long-term therapy: consider magnesium (especially if on diuretics/digoxin), vitamin B12 with prolonged use, and fracture risk/bone health in at-risk patients; monitor INR if used with warfarin; consider liver enzymes in significant hepatic disease.

Pharmacology

Mechanism of Action

Pantoprazole is a proton pump inhibitor that irreversibly inhibits the gastric parietal cell H+/K+-ATPase (proton pump), blocking the final step of acid secretion.

Onset of Action

Initial acid suppression begins within a few hours (about 2-3 hours), but maximal clinical effect typically requires 2-4 days of daily dosing.

Duration of Effect

Approximately 24 hours per dose (acid suppression persists about a day, though maximal effect requires several days of dosing).

Half-Life

Approximately 1 hour (about 1-1.5 hours in healthy adults).

Bioavailability

Approximately 77%.

Metabolism

Extensively hepatic metabolism, primarily via CYP2C19 with a minor contribution from CYP3A4 (with first-pass metabolism).

Excretion

Approximately 71% excreted in urine (mainly as metabolites) and ~18% in feces/bile.

Protein Binding

Approximately 98%, primarily to albumin.

Product Information

Available Dosage Forms

Enteric‑coated (delayed‑release) oral tablet (this product: 20 mg EC tablet). Other pantoprazole dosage forms that may exist in the market include delayed‑release granules/oral suspension and IV injection, but they are not this product.

Composition per Dose

Each enteric-coated tablet: 20mg pantoprazole as pantoprazole sodium sesquihydrate.

Generic Availability

Yes

OTC Alternatives

OTC alternatives for mild/intermittent reflux symptoms (market-dependent): antacids (e.g., aluminum/magnesium hydroxide, calcium carbonate) and H2 blockers (e.g., famotidine). OTC omeprazole is available in some countries, but this specific product (pantoprazole 20 mg EC) is prescription-only per SFDA.

Gi Condition

Acid Reflux/GERD, Ulcer

Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 07-08-2026